Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis - 07/09/11
Abstract |
Background: Although topical application of aluminium chloride is the most common measure against axillary sweating, severely affected patients often undergo surgical procedures that are expensive and may have considerable side effects. Recently botulinum toxin A (BT-A) has been reported as a potentially effective antihyperhidrotic agent. Objective: Our purpose was to determine the therapeutic strength, safety, and mode of application of BT-A in severe axillary hyperhidrosis. Methods: Intradermal injection of BT-A (Dysport) was given in an open left-versus-right side trial with each patient being his own control for initial efficacy, followed by treatment of the contralateral side. Results: Seven days after initial treatment sweat production fell to below 10% of the untreated contralateral axilla as determined by gravimetry. Satisfaction was rated unanimously as “very good,” the highest of 5 rankings. No side effects such as skin irritation or muscle weakness were noted in any patient. Conclusion: Intradermal injection of BT-A is a potent and well-accepted therapeutic option in patients with recalcitrant axillary hyperhidrosis. (J Am Acad Dermatol 1999;41:987-90.)
Le texte complet de cet article est disponible en PDF.Plan
Supported by a grant from an investigator-initiated study from the Departments of Dermatology and Neurology. |
|
Reprint requests: Marc Heckmann, MD, Dermatologische Klinik, Frauenlobstr 9-11, 80337, Munich, Germany. E-mail: heckmann@derma.med.uni-muenchen.de. |
|
0190-9622/99/$8.00 + 0 16/1/101082 |
Vol 41 - N° 6
P. 987-990 - décembre 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?